UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia
Completed · Not applicable
Conditions studied: Cervical Cancer, Precancerous/Nonmalignant Condition
In brief
RATIONALE: Tretinoin may help cervical neoplasia cells develop into normal cervical cells. It is not yet known whether tretinoin is more effective than a placebo in preventing cervical cancer in patients with cervical neoplasia. PURPOSE: Randomized clinical trial to study the effectiveness of tretinoin in preventing cervical neoplasia from developing into cervical cancer.
Key facts
- Study ID
- NCT00003598
- Run by
- University of Michigan Rogel Cancer Center
- People needed
- 180
- Starts
- 1999-01-01
- Expected to finish
- 2009-11-01
- Last updated by the study team
- 2010-09-22
Who can join
Age: 14 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.